According to the most recent perioperative cardiovascular medication guidelines, which drug combinations are contraindicated or should not be co‑administered with beta‑blockers in patients undergoing non‑cardiac surgery? | Rounds According to the most recent perioperative cardiovascular medication guidelines, which drug combinations are contraindicated or should not be co‑administered with beta‑blockers in patients undergoing non‑cardiac surgery? | Rounds
Loading...

According to the most recent perioperative cardiovascular medication guidelines, which drug combinations are contraindicated or should not be co‑administered with beta‑blockers in patients undergoing non‑cardiac surgery?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: May 14, 2026 · View editorial policy

Perioperative Beta-Blocker–Related Contraindicated/Non–Co-Administered Combinations

The most recent perioperative cardiovascular medication guidance for noncardiac surgery does not list a specific set of absolute drug–drug contraindications for coadministration with existing beta-blockers. (oegari.at)

Instead, the 2024 AHA/ACC/Multisociety perioperative guideline identifies perioperative medication starts that should not be done because of clinically important harms that are pharmacodynamically aligned with beta-blocker adverse effects (bradycardia and hypotension). (oegari.at)

Perioperative Low-Dose Clonidine (Alpha-2 Receptor Agonist)

Perioperative initiation of low-dose clonidine is not recommended in patients undergoing noncardiac surgery to reduce cardiovascular risk. 2024 AHA/ACC perioperative guideline: COR 3 (No benefit) (oegari.at)

In the supporting POISE-2 trial regimen, patients receiving clonidine had significantly more:

  • Nonfatal cardiac arrest
  • Clinically significant bradycardia
  • Clinically significant hypotension (oegari.at)

Because bradycardia and hypotension are key overlapping adverse effects of beta-blockers, perioperative clonidine initiation should be avoided during the beta-blocker perioperative period. (oegari.at)

Perioperative Initiation of Beta-Blockers on the Day of Surgery (Beta-Blocker Start Strategy)

Initiation of beta-blockers on the day of surgery is harmful in patients undergoing noncardiac surgery, particularly when started at higher doses. [2024 AHA/ACC perioperative guideline supportive text] (https://www.oegari.at/web_files/cms_daten/2024-aha-acc-guideline-for-perioperative-cardiovascular-management.pdf) (oegari.at)

If beta-blocker initiation is required preoperatively, the guideline states the medication should be initiated ≥7 days before surgery to permit tolerability assessment and titration and to reduce harm associated with very short preoperative initiation windows. (oegari.at)

Summary of Medication Combinations to Avoid With Beta-Blockers in the Perioperative Period

  • Do not initiate perioperative low-dose clonidine (alpha-2 agonist) because of increased bradycardia/hypotension and other harms in POISE-2, which clinically overlap with beta-blocker effects. (oegari.at)
  • Do not initiate beta-blockers on the day of surgery; start timing should be ≥7 days preoperatively if initiation is indicated. (oegari.at)

Related Questions